ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Chronos Therapeutics Limited

Chronos Therapeutics Limited is an active company incorporated on 5 March 2009 with the registered office located in Macclesfield, Cheshire. Chronos Therapeutics Limited was registered 16 years ago.
Status
Active
Active since incorporation
Company No
06838479
Private limited company
Age
16 years
Incorporated 5 March 2009
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 5 March 2025 (8 months ago)
Next confirmation dated 5 March 2026
Due by 19 March 2026 (4 months remaining)
Last change occurred 7 months ago
Accounts
Submitted
For period 1 Apr31 Mar 2025 (12 months)
Accounts type is Total Exemption Full
Next accounts for period 31 March 2026
Due by 31 December 2026 (1 year 1 month remaining)
Address
Theracryf Plc Alderley Park
Congleton Road
Nether Alderley
SK10 4TG
United Kingdom
Address changed on 16 May 2024 (1 year 5 months ago)
Previous address was , C/O Evgen Pharma, Suite 24G13 - Block 24 Alderley Park, Congleton Road, Nether Alderley, SK10 4TG, United Kingdom
Telephone
01865518910
Email
Available in Endole App
People
Officers
2
Shareholders
1
Controllers (PSC)
1
Director • British • Lives in UK • Born in Nov 1959
Director • Finnish • Lives in Switzerland • Born in Dec 1977
Theracryf Plc
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
No mutual companies found
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Mar 2024
For period 31 Dec31 Mar 2024
Traded for 15 months
Cash in Bank
£9K
Decreased by £50K (-85%)
Turnover
Unreported
Same as previous period
Employees
1
Same as previous period
Total Assets
£525K
Decreased by £120K (-19%)
Total Liabilities
-£166K
Increased by £157K (+1744%)
Net Assets
£359K
Decreased by £277K (-44%)
Debt Ratio (%)
32%
Increased by 30.22% (+2166%)
Latest Activity
Full Accounts Submitted
4 Days Ago on 7 Nov 2025
Confirmation Submitted
7 Months Ago on 8 Apr 2025
Full Accounts Submitted
11 Months Ago on 10 Dec 2024
Accounting Period Extended
1 Year 2 Months Ago on 5 Sep 2024
Registered Address Changed
1 Year 5 Months Ago on 16 May 2024
Theracryf Plc (PSC) Appointed
1 Year 7 Months Ago on 5 Apr 2024
Dr Huw Jones Appointed
1 Year 7 Months Ago on 5 Apr 2024
Michael Moore Resigned
1 Year 7 Months Ago on 5 Apr 2024
Shawn David Manning Resigned
1 Year 7 Months Ago on 5 Apr 2024
Toni Markus Antero Haenninen Appointed
1 Year 7 Months Ago on 5 Apr 2024
Get Credit Report
Discover Chronos Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Total exemption full accounts made up to 31 March 2025
Submitted on 7 Nov 2025
Confirmation statement made on 5 March 2025 with updates
Submitted on 8 Apr 2025
Notification of Theracryf Plc as a person with significant control on 5 April 2024
Submitted on 28 Mar 2025
Withdrawal of a person with significant control statement on 28 March 2025
Submitted on 28 Mar 2025
Total exemption full accounts made up to 31 March 2024
Submitted on 10 Dec 2024
Previous accounting period extended from 31 December 2023 to 31 March 2024
Submitted on 5 Sep 2024
Appointment of Dr Huw Jones as a director on 5 April 2024
Submitted on 16 May 2024
Registered office address changed from , C/O Evgen Pharma, Suite 24G13 - Block 24 Alderley Park, Congleton Road, Nether Alderley, SK10 4TG, United Kingdom to Theracryf Plc Alderley Park Congleton Road Nether Alderley SK10 4TG on 16 May 2024
Submitted on 16 May 2024
Termination of appointment of Martin Henry Diggle as a director on 5 April 2024
Submitted on 19 Apr 2024
Registered office address changed from , 6-7 Citibase, New Barclay House 234 Botley Road, Oxford, OX2 0HP, England to Theracryf Plc Alderley Park Congleton Road Nether Alderley SK10 4TG on 19 April 2024
Submitted on 19 Apr 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year